Crystal of 1,3,5-triazine derivative or solvate thereof and method for producing same
WO2021049600A1
Pharmaceutical composition having antibacterial activity
WO2021050708A1
Benzyl amine-containing 5,6-heteroaromatic compounds useful against mycobacterial infection
WO2021020412A1
Nucleic acid drug targeting murf1
WO2020246443A1
Production method for bifurcated lipid-linked oligonucleotide, and intermediate
JP2020197531A
Standard product for bnp measurement including a protease inhibitor
WO2020243224A1
A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE
WO2020209249A1
Dissolution test net
US2020297731A1
Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition
WO2020184399A1
Antibacterial pharmaceutical composition
WO2020179701A1
Contaminant-depleted nanoparticle composition and method for producing same
WO2020145369A1
Dihydropyrazolopyrazinone derivative having mgat2 inhibitory activity
JP2020111571A
Pharmaceutical composition containing fused ring derivative with mgat2 inhibitory activity
WO2020116447A1
Solid dispersion of poorly soluble drug
WO2020071530A1
Medicine for treating chronic cough
WO2020009179A1
Fused heterocyclic derivatives having selective bace1 inhibitory activity
